Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Digital Pathology Market, by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030.

The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030.

Market Overview:

Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology and specialized software. It involves capturing high-resolution images of the glass slides, converting them into a digital format, and then viewing, managing, and analyzing the images on a computer or other digital devices.

Competitive Landscape:

Major players operating in the global Digital Pathology Market include Nucleai, Inc., Xybion Digital Inc., Aiforia, MD Biosciences, OracleBio Limited, Hamamatsu Photonics, Inc., Inspirata, Inc., Propath UK Limited, Sectra AB, Koninklijke Philips N.V., Mikroscan Technologies, Inc., GE Healthcare, Merck KGaA, F. Hoffmann-La Roche Ltd., Olympus Corporation, and Leica Biosystems Nussloch GmbH.

Key Market Drivers:

Advancements in imaging technologies, such as whole-slide imaging (WSI), high-resolution imaging, and automation, have significantly enhanced the accuracy and efficiency of digital pathology. These technological advancements have facilitated the transition from traditional microscopy to digital pathology. This is expected to augment the growth of the global Digital Pathology Market. For instance, in June 2022, F. Hoffmann-LA Roche Ltd. introduced a slide scanner called VENTANA DP 600, in order to enhance advanced patient care along with accurate diagnostics.

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and infectious diseases, has led to a growing demand for accurate and timely diagnosis. Digital pathology offers benefits like rapid image analysis, remote consultations, and efficient storage and retrieval of patient data, thereby supporting the diagnosis and management of chronic diseases.

Digital pathology streamlines the workflow by eliminating the need for physical slides, reducing the time and cost associated with slide transportation, storage, and retrieval. It also allows pathologists to work remotely and collaborate effectively, leading to improved productivity and cost savings for healthcare institutions. This is estimated to enhance the growth of the global Digital Pathology for Market.

Telepathology, enabled by digital pathology, allows pathologists to remotely review and diagnose cases, facilitating access to expert opinions and reducing the burden of limited pathology expertise in underserved areas. The increasing adoption of telepathology services has contributed to the market growth.

Covid-19 Impact Analysis:

The COVID-19 pandemic led to an overwhelming demand for pathology services due to the diagnosis and monitoring of COVID-19 cases. Digital pathology emerged as a crucial tool in facilitating remote consultations and collaboration among pathologists, thereby ensuring continuity in diagnostic services during lockdowns and travel restrictions. This boosted the growth of the global Digital Pathology Market. For instance, in October 2021, Koninklijke Philips introduced an advanced digital pathology solution. The solution will be featuring a scalable and comprehensive suite of digital pathology software tools.

Key Takeaways:

· North America is expected to dominate the growth of the global digital pathology for market, owing to the advanced healthcare infrastructure, early technology adoption, and a large patient population. The presence of key market players and increasing investments in research and development further contribute to the growth of this region. For instance, in September 2022, Danaher Corporation and Indica Labs partnered in order to deliver digital pathology workflow solutions.

· The Asia Pacific is estimated to witness high growth in the global Digital Pathology Market, owing to the increasing prevalence of chronic diseases, improving healthcare infrastructure, and a rising geriatric population. Countries like China and India are witnessing substantial investments in digital pathology to address the healthcare needs of their large populations. For instance, in October 2022, the United States Food and Drug Administration gave clearance to Hamamatsu's NanoZoomer S360MD Slide scanner system, in order to use it for diagnosis.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more